Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | BAD |
| Upstream (Parents) |
|---|
| (<<) BBS1 → BAD |
| (<<) HRAS → BAD |
| (<<) MLX → BAD |
| (<<) OSBPL8 → BAD |
| (<<) PRKCH → BAD |
| (<<) RB1 → BAD |
| (<<) SHC2 → BAD |
| (<<) TK2 → BAD |
| Downstream (Children) |
|---|
| BAD → DHX9 (>>) |
| BAD → FER1L4 (>>) |
| BAD → GPX4 (>>) |
| BAD → GRK6 (>>) |
| BAD → LOC92249 (>>) |
| BAD → MAP3K1 (>>) |
| BAD → MAP3K11 (>>) |
| BAD → MAP3K6 (>>) |
| BAD → NFKBIB (>>) |
| BAD → PPP2R5B (>>) |
| BAD → RHOD (>>) |
| BAD → RHOT2 (>>) |
| BAD → RPS6KB2 (>>) |
| BAD → SH3GL1 (>>) |
| BAD → SOCS6 (>>) |
| BAD → TNF (>>) |
| BAD → VEGFB (>>) |
